List of Excipients in API albumin (human)
✉ Email this page to a colleague
Detailed excipient profiles for albumin (human)
Excipient focus: ACETIC ACID
albumin (human) drug variants containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring LLC | albumin (human) | 0053-7680 |
| >Company | >Ingredient | >NDC |
albumin (human) drug variants not containing ACETIC ACID
Excipient focus: ACETYLTRYPTOPHAN, DL-
albumin (human) drug variants containing ACETYLTRYPTOPHAN, DL-
albumin (human) drug variants not containing ACETYLTRYPTOPHAN, DL-
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring LLC | albumin (human) | 0053-7680 |
| CSL Behring AG | albumin (human) | 44206-251 |
| CSL Behring AG | albumin (human) | 44206-310 |
| GRIFOLS USA LLC | albumin (human) | 61953-0001 |
| GRIFOLS USA LLC | albumin (human) | 61953-0002 |
| GRIFOLS USA LLC | albumin (human) | 68516-5214 |
| GRIFOLS USA LLC | albumin (human) | 68516-5215 |
| >Company | >Ingredient | >NDC |
Excipient focus: N-ACETYL-DL-TRYPTOPHAN SODIUM
albumin (human) drug variants containing N-ACETYL-DL-TRYPTOPHAN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring AG | albumin (human) | 44206-251 |
| CSL Behring AG | albumin (human) | 44206-310 |
| GRIFOLS USA LLC | albumin (human) | 68516-5214 |
| >Company | >Ingredient | >NDC |
albumin (human) drug variants not containing N-ACETYL-DL-TRYPTOPHAN SODIUM
Excipient focus: POTASSIUM CHLORIDE
albumin (human) drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring AG | albumin (human) | 44206-251 |
| CSL Behring AG | albumin (human) | 44206-310 |
| >Company | >Ingredient | >NDC |
albumin (human) drug variants not containing POTASSIUM CHLORIDE
Excipient focus: SODIUM ACETYLTRYPTOPHANATE
albumin (human) drug variants containing SODIUM ACETYLTRYPTOPHANATE
| Company | Ingredient | NDC |
|---|---|---|
| GRIFOLS USA LLC | albumin (human) | 61953-0001 |
| GRIFOLS USA LLC | albumin (human) | 61953-0002 |
| GRIFOLS USA LLC | albumin (human) | 68516-5215 |
| GRIFOLS USA LLC | albumin (human) | 68516-5216 |
| >Company | >Ingredient | >NDC |
albumin (human) drug variants not containing SODIUM ACETYLTRYPTOPHANATE
Excipient focus: SODIUM BICARBONATE
albumin (human) drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring LLC | albumin (human) | 0053-7680 |
| >Company | >Ingredient | >NDC |
albumin (human) drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM CAPRYLATE
albumin (human) drug variants containing SODIUM CAPRYLATE
albumin (human) drug variants not containing SODIUM CAPRYLATE
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring LLC | albumin (human) | 0053-7680 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
albumin (human) drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring LLC | albumin (human) | 0053-7680 |
| CSL Behring AG | albumin (human) | 44206-251 |
| CSL Behring AG | albumin (human) | 44206-310 |
| GRIFOLS USA LLC | albumin (human) | 61953-0001 |
| GRIFOLS USA LLC | albumin (human) | 61953-0002 |
| GRIFOLS USA LLC | albumin (human) | 68516-5214 |
| GRIFOLS USA LLC | albumin (human) | 68516-5215 |
| >Company | >Ingredient | >NDC |
albumin (human) drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
albumin (human) drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring LLC | albumin (human) | 0053-7680 |
| >Company | >Ingredient | >NDC |
albumin (human) drug variants not containing SODIUM HYDROXIDE
Excipient focus: WATER
albumin (human) drug variants containing WATER
albumin (human) drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| CSL Behring LLC | albumin (human) | 0053-7680 |
| CSL Behring AG | albumin (human) | 44206-251 |
| CSL Behring AG | albumin (human) | 44206-310 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch